Simplex Trading’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Simplex Trading’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-95	Closed	-$47	–	10393
2023 Q2	$0	Buy	+95	New	+$612	﹤0.01%	10490

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Simplex Trading's BLPH Position: Q3 2023 in Review

Simplex Trading sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q3 2023, closing a stake of 95 shares — an estimated $47 sold.

Simplex Trading first reported a position in BLPH in Q2 2023 and held it in 1 quarter. The position peaked at $0 in Q2 2023. 22 funds tracked by Wall St. Rank hold BLPH as of Q3 2023.

Simplex Trading reported no remaining Bellerophon Therapeutics, Inc. position as of Q3 2023 after selling out during the quarter.
Simplex Trading sold 95 Bellerophon Therapeutics, Inc. shares in Q3 2023, an estimated $47.
Simplex Trading first reported a position in Bellerophon Therapeutics, Inc. in Q2 2023 and held it in 1 quarter.
Simplex Trading's Bellerophon Therapeutics, Inc. position peaked at $0 in Q2 2023.
22 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.